-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P60CmLF45bZlFa6BHymA4DMidI4PwetldPQg/dslKKDmRMetx7c5TH84Y7DZoE0y vUTeyDAEg6djv9z+kQWeeQ== 0001036050-98-000261.txt : 19980226 0001036050-98-000261.hdr.sgml : 19980226 ACCESSION NUMBER: 0001036050-98-000261 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19980225 SROS: NONE GROUP MEMBERS: 399 VENTURE PARTNERS, INC GROUP MEMBERS: CITIBANK, N.A. GROUP MEMBERS: CITICORP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SYBRON CHEMICALS INC CENTRAL INDEX KEY: 0000832815 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 510301280 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-45069 FILM NUMBER: 98548880 BUSINESS ADDRESS: STREET 1: BIRMINGHAM RD STREET 2: PO BOX 66 CITY: BIRMINGHAM STATE: NJ ZIP: 08011 BUSINESS PHONE: 6098931100 MAIL ADDRESS: STREET 1: P O BOX 66 BIRMINGHAM ROAD CITY: BIRMINGHAM STATE: NJ ZIP: 08011 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CITICORP CENTRAL INDEX KEY: 0000020405 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 132614988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 399 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10043 BUSINESS PHONE: 2125591000 MAIL ADDRESS: STREET 1: 425 PARK AVE- 2ND F STREET 2: ATTN: LEGAL AFFAIRS OFFICE CITY: NEW YORK STATE: NY ZIP: 10043 FORMER COMPANY: FORMER CONFORMED NAME: FIRST NATIONAL CITY CORP DATE OF NAME CHANGE: 19740414 FORMER COMPANY: FORMER CONFORMED NAME: CITY BANK OF NEW YORK NATIONAL ASSOCIATI DATE OF NAME CHANGE: 19680903 SC 13D 1 SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a) SYBRON CHEMICALS INC. - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, $.01 PAR VALUE - -------------------------------------------------------------------------------- (Title of Class of Securities) 870903 10 1 __________________ (CUSIP Number) DECHERT PRICE & RHOADS 4000 Bell Atlantic Tower 1717 Arch Street Philadelphia, PA 19103 Attention: G. Daniel O' Donnell, Esquire (215) 994-2762 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) February 25, 1998 _______________________________ (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box /X/. Note: Six copies of this Statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. The remainder of this coverage shall be filed out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). -1- SCHEDULE 13D - -------------------------------------------------------------------------------- CUSIP NO. 870903 10 1 Page 2 of 13 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 399 VENTURE PARTNERS, INC. I.R.S. ID NO. 13-3413727 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 2,025,000 OWNED BY --------------------------------------------------------- EACH REPORTING 8 SHARED VOTING POWER PERSON WITH None --------------------------------------------------------- 9 SOLE DISPOSITIVE POWER 2,025,000 --------------------------------------------------------- 10 SHARED DISPOSITIVE POWER NONE - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,025,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 35.7% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- -2- SCHEDULE 13D - -------------------------------------------------------------------------------- CUSIP NO. 870903 10 1 Page 3 of 13 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Citibank, N.A. I.R.S. ID NO. 13-5266470 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(c) [X] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION A National Banking Association - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 2,025,000 ------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH REPORTING None ------------------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 2,025,000 ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER None - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 399 Venture Partners, Inc., a wholly-owned subsidiary of Citibank, N.A., beneficially and directly owns the 2,025,000 shares referred to herein. Citibank, N.A. is a wholly-owned subsidiary of Citicorp. - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 35.7% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- -3- SCHEDULE 13D - -------------------------------------------------------------------------------- CUSIP No. 870903 10 1 Page 4 of 13 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) CITICORP I.R.S ID. NO. 13-2614988 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [X] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 2,025,000 ---------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH REPORTING None ---------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 2,025,000 ---------------------------------------------- 10 SHARED DISPOSITIVE POWER None - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 399 Venture Partners, Inc., a wholly-owned subsidiary of Citibank, N.A., beneficially and directly owns the 2,025,000 shares referred to herein. Citibank, N.A., is a wholly-owned subsidiary of Citicorp. - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 35.7% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- -4- SCHEDULE 13D This Statement on Schedule 13D (the "Statement") is being filed pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). ITEM 1. SECURITY AND ISSUER. This Statement relates to shares of the common stock, par value $.01 per share, (individually, a "Share" and collectively, the "Shares") of Sybron Chemicals Inc., a Delaware corporation ("Sybron"), with its principal executive offices at Birmingham Road, Birmingham, New Jersey 08011. ITEM 2. IDENTITY AND BACKGROUND. (a) This Statement is being filed jointly pursuant to Rule 13d-1(f)(1) ("Rule 13d-1(f)(1)") promulgated under the Exchange Act by: (1) 399 Venture Partners, Inc., a Delaware corporation ("399 Venture"), formerly known as Citicorp Investments Inc., (2) Citibank, N.A., a national banking association ("Citibank"); and (3) Citicorp, a Delaware corporation ("Citicorp") (hereinafter, each such person or entity may be referred to individually as a "Reporting Person" and collectively as the "Reporting Persons"). (b) The address of the principal business office of each Reporting Person is as follows: Reporting Person Address 399 Venture Partners, Inc. 399 Park Avenue New York, New York 10043 Citibank, N.A. 399 Park Avenue New York, New York 10043 Citicorp 399 Park Avenue New York, New York 10043 (c) 399 Venture is a wholly-owned subsidiary of Citibank. 399 Venture is a small business investment company which is primarily engaged in making equity investments. Citibank is a wholly-owned subsidiary of Citicorp. Citibank is principally engaged in the general banking business. Citicorp is a multi-bank holding company principally engaged, through its subsidiaries, in the general financial services business. (d) During the last five years, none of the Reporting Persons, and to the knowledge of each Reporting Person, none of the executive officers or directors of 399 Venture, Citibank or Citicorp, have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) Except as described herein, during the last five years, none of the Reporting Persons, and to the knowledge of each Reporting Person, none of the executive officers or directors of such -5- Reporting Person, as applicable, have been a party to an civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such person or entity was or is subject to a judgment, decree or final order in joining future violation of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. In 1992 Citibank consented to orders issued by the Securities and Exchange Commission (the "SEC") and the Comptroller of the Currency, without admitting or denying allegations and findings, with respect to findings that Citibank violated certain securities laws in its role as a transfer agent with respect to the proper safeguarding and destruction of canceled securities certificates. The orders, and related facts and circumstances, were described in Current Reports on Form 8-K, dated July 21, 1992, and January 19, 1993, that Citicorp previously filed with the SEC. (f) Citicorp is a Delaware corporation. Citibank is a national banking association. 399 Venture is a Delaware corporation. Except as indicated on Annex A, to the knowledge of Citicorp, Citibank and 399 Venture, each executive officer or director of such Reporting Person is a citizen of the United States. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. The Shares were acquired by the Reporting Persons in July, 1987 pursuant to the acquisition by Sybron of the Sybron Chemical Group from Sybron Corporation. The funds used to purchase the Shares came from the Reporting Persons' investment capital. ITEM 4. PURPOSE OF TRANSACTION. 399 Venture currently holds the Shares as an investment. 399 Venture may, subject to applicable securities laws, applicable laws regulating the percentage of voting securities of Sybron that 399 Venture may own, market conditions and its assessment of the business prospects of Sybron, acquire additional Shares of Sybron from time to time through open market purchases or otherwise, as it determines in its sole discretion. 399 Venture is continuously evaluating the business and business prospects of Sybron, and its present and future interests in, and intentions with respect to, Sybron and may at any time decide to dispose of any or all of the Shares currently owned by 399 Venture. Other than as discussed above, 399 Venture currently has no plans to effect: (a) any extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving Sybron or any of its subsidiaries; (b) a sale or transfer of a material amount of the assets of Sybron or any of its subsidiaries; (c) any change in the present Board of Directors or management of Sybron, including any change in the number or term of directors or the filling of any vacancies of the Board of Directors; (d) any material change in the present capitalization or dividend policy of Sybron; (e) any other material change in Sybron business or corporate structure; -6- (f) any change in Sybron's charter, by-laws or instruments corresponding thereto or any other actions which may impede the acquisition of control of Sybron by any person; (g) the delisting of any class of securities of Sybron from a national securities exchange or the ceasing to be authorized to be quoted in an interdealer quotation system of a registered national securities association; (h) any class of equity securities of Sybron becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934; or (i) any action similar to any of those enumerated above. 399 Venture intends to re-evaluate continuously its investment in Sybron and may, based on such re-evaluation, determine at a future rate to change its current position with respect to any action enumerated above. ITEM 5. INTEREST IN SECURITIES OF THE ISSURER. (a) 399 Venture is the record and beneficial owner of 2,025,000 Shares or approximately 35.7% of the issued and outstanding Shares. 399 Venture is a wholly owned subsidiary of Citibank, N.A., and Citibank, N.A. is a wholly owned subsidiary of Citicorp. Citibank, N.A. and Citicorp own no Shares directly. (b) 399 Venture has sole ownership of, and voting and dispositive powers over, 2,025,000 Shares. Citicorp and Citibank, N.A. own no Shares directly. (c) None. (d) Not applicable. (e) Not applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSURER. To the extent such information was available on the date hereof, to the knowledge of each Reporting Person on the date hereof, except as set forth herein or in the Exhibits, if any, filed herewith, no Reporting Person nor any of its executive officers or directors, as applicable, has any other contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to securities issued by Sybron, including, but not limited to, transfer or voting of any such securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, divisions of profits or loss or the giving or withholding of proxies. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Exhibit Description Page Exhibit 1 Amended and Restated Joint Filing 13 -7- Agreement, date February 25, 1998 among 399 Venture, Citibank, N.A., and Citicorp. -8- SIGNATURES After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. In executing this statement, the undersigned agree, to the extent required by Rule 13d-1(f), that this statement is being filed on behalf of each of the reporting persons herein. Dated: February 25, 1998 399 VENTURE PARTNERS,INC. By: /s/ Paul C. Schorr IV ------------------------------------ Name: Paul C. Schorr IV Title: Vice President CITIBANK, N.A. By: /s/ Mary Lynn Putney ------------------------------------ Name: Mary Lynn Putney Title: Managing Director CITICORP By: /s/ Ann M. Goodbody ------------------------------------ Name: Ann M. Goodbody Title: Vice President -9- ANNEX A SCHEDULE 13D RELATING TO COMMON SHARES OF SYBRON CHEMICALS INC. (Parenthetical references are to the county of citizenship of persons who are not United States citizens) Citicorp Directors Executive Officers Alain J.P. Belde (Brazil) William I. Campbell (Canada) D. Wayne Calloway Paul J. Collins Paul J. Collins Edward Horowitz Kenneth T. Derr Thomas E. Jones (England) John M. Deutch Charles E. Long Ruben Mark Dionisio R. Martin (Argentina) Richard D. Parsons Robert A. McCormack John S. Reed Victor J. Menezes (India) William R. Rhodes Lawrence R. Phillips Roseanne L. Ridgeway John S. Reed H. Onno Ruding (Netherlands) William R. Rhodes Robert B. Shapiro John J. Roone Frank A. Shrontz H. Onno Ruding (Netherlands) Franklin A. Thomas Mary Alice Taylor Edgar S. Woolard, Jr. Citibank Directors Executive Officer D. Wayne Calloway Paul J. Collins Paul J. Collins Edward Horowitz -10- John M. Deutch Edward Horowitz Ruben Mark Thomas E. Jones (England) Richard D. Parsons Charles E. Long John S. Reed Dionisio R. Martin (Argentina) William R. Rhodes Robert A. McCormack Roseanne L. Ridgeway Victor J. Menezes (India) Robert B. Shapiro Lawrence R. Phillips Frank A. Shrontz John S. Reed Franklin A. Thomas William R. Rhodes John J. Roone H. Onno Ruding (Netherlands) Mary Alice Taylor 399 Venture Partners, Inc. Directors Executive Officers William T. Comfort, Jr. William T. Comfort Ann M. Goodbody David F. Thomas Thomas E. Jones Bryon L. Knief Frederick A. Roesch Richard M. Cashin Charles E. Corpening Michael A. Delaney Noelle M. Doumar David Y. Howe Richard E. Mayberry Thomas F. McWilliams M. Saleem Muqaddam Paul C. Schorr -11- Joseph M. Silvestri James A. Urry John D. Weber Lauren M. Connelly Helene B. Shavin Thomas H. Sanders -12- EX-1 2 UNDERWRITING AGREEMENT EXHIBIT 1 Exhibit 1 Amended and Restated Filing Agreement dated February 25, 1998 Re: Joint Filing of Schedule 13D The undersigned hereby agree that: (i) each of them is individually eligible to use the Schedule 13D attached hereto; (ii) the attached Schedule 13D is filed on behalf of each of them; (iii) each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information therein concerning himself or itself; but none of them is responsible for the completeness and accuracy of the information concerning the other persons making the filing, unless he or it knows or has reason to believe that such information is inaccurate. 399 VENTURE PARTNERS, INC. By: /s/ Paul C. Schorr IV --------------------------- Name: Paul C. Schorr IV Title: Vice President CITIBANK, N.A. By: /s/ Mary Lynn Putney --------------------------- Name: Mary Lynn Putney Title: Managing Director CITICORP By: /s/ Ann M. Goodbody --------------------------- Name: Ann M. Goodbody Title: Vice President -----END PRIVACY-ENHANCED MESSAGE-----